Pilot Trial of Backwards Walking in Persons With Multiple Sclerosis
Pilot Trial of Backwards Walking in Persons With Multiple Sclerosis
What it found
We found no results in the registry or in papers.
What was tested
Treatment tested
- Backwards Walking
Compared with
- Forwards Walking
What it measured
Main measures
Spatiotemporal Walking Parameters from Gaitrite Mat
Change in Baseline Spatiotemporal Walking parameters from Gaitrite Mat after 8 week intervention
Walking and mobilityGait Speed (Timed 25 Foot Walk)
Change in f Baseline Gait Speed (Timed 25 Foot Walk) after 8 week intervention
Disability progressionWalking and mobilitySingle Leg Stance (SLS)
Change in Baseline SLS after 8 week intervention
Other measures (2)
Timed-up and Go
Change in Baseline TUG after 8 week intervention
Activities-Specific Balance Confidence Scale (ABC)
Change in Baseline ABC after 8 week intervention
Walking and mobility
Who could take part
MS (type not specified) · 18 to 65
Show the full criteria
Inclusion criteria
* Confirmed clinical diagnosis of MS * Cognitively able to understand directions and complete protocol (score of 22 or greater on MMSE) * Signed Consent form approved by the Saint Francis Institutional Review Board * 18-65 years of age * PDDS score of 3 to 5 during the past 12 months * Completion of the 6 minute walk test * Speaks English (in order to safely complete intervention)
Exclusion criteria
* Unwilling or unable to complete assessments and intervention * Current participation in physical therapy * Major changes in exercise habits in the past three months * Has had a relapse, acute Solumedrol treatment, or Acthar treatment in the past two months * Requires constant bilateral assistance (canes or crutches) for ambulation and/or cannot walk at least 100 meters without resting * Current self-reported medical history of unstable angina, uncontrolled cardiac dysrhythmias causing symptoms, symptomatic severe aortic stenosis, uncontrolled symptomatic heart failure, acute pulmonary embolus or pulmonary infarction, history of DVT, acute myocarditis or pericarditis, acute systemic infection, uncontrolled hypertension, and uncontrolled diabetes [11] * Participants that cannot adhere to the protocol, have an abnormal response to exercise, or is determined to be unsafe may be withdrawn at the discretion of the Principal Investigator
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
There have been no published studies to date on the effects of backwards walking in persons with MS. Thus it is important that the investigators explore different methods for treatment to help improve balance and gait and prevent injury in persons with MS with gait disturbances and balance impairments.The overall goal of this research is to collect pilot data on the effectiveness of backwards walking as a therapy for improving spatiotemporal, clinical gait and balance assessments in persons with Multiple Sclerosis compared to forward walking.
Loading reviews and guidelines…
History
Started
Apr 2016
Main results due
Feb 2018
Finished
Feb 2018